Protocol Ledger

NCT07530887 · Phase III · RECRUITING

NO Re-excision MelanomA - NORMA 2

Interventional Phase III clinical trial protocol NCT07530887 sponsored by Marieke Goodijk in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-11-13 Enrollment: 1,749 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07530887
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,749 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07530887
Protocol FieldVerified Registry Value
NCT IdentifierNCT07530887
Consolidated Lead SponsorMarieke Goodijk
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,749 participants (ESTIMATED)
Registered Start Date2025-11-13
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI